» Articles » PMID: 11409907

Non-infectious Complications of Transfusion Therapy

Overview
Journal Blood Rev
Publisher Elsevier
Specialty Hematology
Date 2001 Jun 21
PMID 11409907
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Blood transfusion is considered safe when the infused blood is tested using state of the art viral assays developed over the past several decades. Only rarely are known viruses like HIV and hepatitis C transmitted by transfusion when blood donors are screened using these sensitive laboratory tests. However, there are a variety of transfusion risks which still remain that cannot be entirely eliminated, many of which are non-infectious in nature. Predominantly immune-mediated complications include the rapid intravascular or slow extravascular destruction (hemolysis) of transfused red cells or extravascular removal of platelets by pre-formed antibodies carried by the transfusion recipient. Alternatively, red cells can be damaged when exposed to excessive heat or incompatible intravenous fluids before or during the transfusion. Common complications of blood transfusion that at least partly involve the immune system include febrile non-hemolytic and allergic reactions. While these are usually not life-threatening, they can hamper efforts to transfuse a patient. Other complications include circulatory overload, hypothermia and metabolic disturbances. Profound hypotensive episodes have been described in patients on angiotensin-converting enzyme (ACE) inhibitors who receive platelet transfusions through bedside leukoreduction filters. These curious reactions appear to involve dysmetabolism of the vasoactive substance bradykinin. Products contaminated by bacteria during blood collection and transfused can cause life-threatening septic reactions. A long-term complication of blood transfusion therapy unique to chronically transfused patients is iron overload. Less common - but serious - reactions more specific to blood transfusion include transfusion-associated graft-versus-host disease and transfusion-associated acute lung injury. Many of these complications of transfusion therapy can be prevented by adhering to well-established practice guidelines. In addition, individuals who administer blood transfusions should recognize these complications in order to be able to quickly provide appropriate treatment.

Citing Articles

Red blood cell transfusion clinical decision support: A scoping review of guideline adherence and clinical impact.

Czako S, Prochaska M Transfusion. 2025; 65(2):410-419.

PMID: 39828901 PMC: 11842101. DOI: 10.1111/trf.18122.


Efficacy and safety of recombinant activated factor VII in Glanzmann thrombasthenia: A systematic literature review.

Saultier P, Grino M, Falaise C, Voisin S, Lavenu-Bombled C, Ibrahim-Kosta M Haemophilia. 2024; 31(1):7-15.

PMID: 39604156 PMC: 11780185. DOI: 10.1111/hae.15130.


Red Cell Alloimmunisation Among Sickle Cell Disease and Thalassemia Patients Following Rh- and K-Matched Red Cell Transfusion in Southwestern Saudi Arabia: A Multicenter Study.

Meshi A, Abu-Tawil H, Hamzi A, Madkhali B, Maghfori A, Alnami I Int J Gen Med. 2024; 17:2855-2864.

PMID: 38947563 PMC: 11212813. DOI: 10.2147/IJGM.S444949.


Evaluation of leukocyte depletion of packed red blood cell units and impact on clinically observed transfusion reactions.

Steblaj B, Galli J, Torgerson P, Kutter A Front Vet Sci. 2023; 10:1217575.

PMID: 37841457 PMC: 10568135. DOI: 10.3389/fvets.2023.1217575.


Finding Potential Adverse Events in the Unstructured Text of Electronic Health Care Records: Development of the Shakespeare Method.

Bright R, Rankin S, Dowdy K, Blok S, Bright S, Palmer L JMIRx Med. 2023; 2(3):e27017.

PMID: 37725533 PMC: 10414364. DOI: 10.2196/27017.